Synapsor
Synapsor (legal entity Ottai Technology (Wuxi) Co. Ltd.) is a Chinese medical-device company based in Wuxi, Jiangsu that develops AI-powered, medical-grade smart wearable devices. Its flagship product is the Ottai continuous glucose monitoring (CGM) system - a waterproof, calibration-free wearable sensor paired with a mobile app and AI assistant for 24/7 glucose tracking and diabetes management, sold in China and internationally via ottai.com. Investors include Qiming Venture Partners, Huatai Zijin Investment, Wuxi Industry Development Group, YuanBio Venture Capital, and Shunwei Capital. Synapsor publishes no public developer API, portal, or machine-readable API specifications as of July 2026.
Synapsor is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Medical Devices, Wearables, and Continuous Glucose Monitoring.
Synapsor’s developer surface includes engineering blog, support, and 6 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 2
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API